Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.071 | 0.7 |
mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.053 | 0.7 |